Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors

Lingjian Zhu,Xianghua Zhang,Ning Lei,Wenfeng Liu,Zhenyuan Miao,Chunlin Zhuang,Chunquan Sheng,Wei Guo,Guoqiang Dong,Jianzhong Yao,Pengfei Cheng,Wannian Zhang

DOI: https://doi.org/10.1002/cbdv.201100195

Abstract:Homocamptothecin (hCPT) is a camptothecin (CPT) derivative with a seven-membered β-hydroxylactone E ring, which shows higher lactone stability and improves topoisomerase I (Topo I) inhibition activity. In an attempt to improve the antitumor activity of homocamptothecins, a series of 7-alkenyl-homocamptothecin derivatives was designed and synthesized based on a semisynthetic route starting from CPT. Most of the synthesized compounds exhibit higher cytotoxic activities on the A-549 tumor cell line than topotecan (TPT). Some compounds such as 2a and 2o show a broad in vitro antitumor spectrum and exhibit superior Topo I-inhibition activity.